Literature DB >> 17078949

A model of tenascin-X integration within the collagenous network.

Claire Lethias1, Alexandre Carisey, Jane Comte, Caroline Cluzel, Jean-Yves Exposito.   

Abstract

Tenascin-X is an extracellular matrix protein whose absence leads to an Ehlers-Danlos syndrome in humans, characterized mainly by disorganisation of collagen and elastic fibril networks. After producing recombinant full-length tenascin-X in mammalian cells, we find that this protein assembled into disulfide-linked oligomers. Trimers were the predominant form observed using rotary shadowing. By solid phase interaction studies, we demonstrate that tenascin-X interacts with types I, III and V fibrillar collagen molecules when they are in native conformation. The use of tenascin-X variants with large regions deleted indicated that both epidermal growth factor repeats and the fibrinogen-like domain are involved in this interaction. Moreover, we demonstrate that tenascin-X binds to the fibril-associated types XII and XIV collagens. We thus suggest that tenascin-X, via trimerization and multiple interactions with components of collagenous fibrils, plays a crucial role in the organisation of extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078949     DOI: 10.1016/j.febslet.2006.10.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome.

Authors:  Walter L Miller; Deborah P Merke
Journal:  Horm Res Paediatr       Date:  2018-05-07       Impact factor: 2.852

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 3.  Tenascins in fibrotic disorders-from bench to bedside.

Authors:  M Kasprzycka; C Hammarström; G Haraldsen
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

4.  Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome.

Authors:  Coen A C Ottenheijm; Nicol C Voermans; Bryan D Hudson; Thomas Irving; Ger J M Stienen; Baziel G van Engelen; Henk Granzier
Journal:  J Appl Physiol (1985)       Date:  2012-01-05

5.  Basic Components of Connective Tissues and Extracellular Matrix: Fibronectin, Fibrinogen, Laminin, Elastin, Fibrillins, Fibulins, Matrilins, Tenascins and Thrombospondins.

Authors:  Jaroslava Halper
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix.

Authors:  Edward B Neufeld; Leah M Zadrozny; Darci Phillips; Angel Aponte; Zu-Xi Yu; Robert S Balaban
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

7.  Tenascin-X in amniotic fluid and reproductive tissues of pregnancies complicated by infection and preterm prelabor rupture of membranes†.

Authors:  Kara M Rood; Catalin S Buhimschi; Guomao Zhao; Emily A Oliver; Taryn Summerfield; Mert Ozan Bahtiyar; Irina A Buhimschi
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

8.  Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome.

Authors:  Munis Dündar; Thomas Müller; Qi Zhang; Jing Pan; Beat Steinmann; Julia Vodopiutz; Robert Gruber; Tohru Sonoda; Birgit Krabichler; Gerd Utermann; Jacques U Baenziger; Lijuan Zhang; Andreas R Janecke
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

Review 9.  Vesicoureteral reflux and the extracellular matrix connection.

Authors:  Fatima Tokhmafshan; Patrick D Brophy; Rasheed A Gbadegesin; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2016-05-02       Impact factor: 3.714

10.  Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure.

Authors:  Pallavi Agarwal; Daniela Zwolanek; Douglas R Keene; Jan-Niklas Schulz; Katrin Blumbach; Dick Heinegård; Frank Zaucke; Mats Paulsson; Thomas Krieg; Manuel Koch; Beate Eckes
Journal:  J Biol Chem       Date:  2012-05-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.